Alphadyne Asset Management LP

Position in DHR — Danaher Corp /De/

CIK 1535943 NEW YORK, NY

Back to DHR Full portfolio

Position in DHR

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$9,248,877

+$9,248,877 QoQ

Shares Held

48,781

Ownership

0.007%

of shares outstanding

% of Portfolio

1.25%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2023

3 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in DHR Over Time

Shares Held

Position Value (USD)

Derivatives in DHR

reported options exposure · as of Mar 31, 2026

CallValue

$6,768,720

CallShares

35,700

PutValue

$11,053,680

PutShares

58,300

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

Alphadyne Asset Management LP holds $368,833 across 2 Diagnostics & Research names.

#	Ticker	Company	Shares	Value (USD)	Open
1	TMO	Thermo Fisher Scientific Inc.	672	$336,913
2	LH	Labcorp Holdings Inc.	114	$31,920

All Filings in DHR

Export CSV

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$11,053,680	58,300	+389.9%	Put	Sole	2026-05-15
2026-03-31	$9,248,877	48,781	+4554.7%	Shares	Sole	2026-05-15
2026-03-31	$6,768,720	35,700	+224.5%	Call	Sole	2026-05-15
2025-12-31	$2,724,148	11,900	+108.8%	Put	Sole	2026-02-17
2025-12-31	$2,518,120	11,000	—	Call	Sole	2026-02-17
2023-06-30	$1,368,000	5,700	—	Put	Sole	2023-08-14
2023-06-30	$251,520	1,048	—	Shares	Sole	2023-08-14
No filing history on record for this holder in this stock.